Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among

Ziming Xuan1,2, Shapei Yan3, Scott W Formica4

  • 1Boston University School of Public Health, Department of Community Health Sciences, Boston, Massachusetts.

JAMA Psychiatry
|March 15, 2023
PubMed
Abstract

Insights

Postoverdose outreach programs in Massachusetts were linked to a significant decrease in opioid overdose deaths over time. These programs connect overdose survivors with vital addiction treatment and harm reduction services, reducing mortality.

Area of Science:

  • Public Health
  • Epidemiology
  • Addiction Medicine

Background:

  • Nonfatal opioid overdose is a primary predictor of fatal overdose.
  • Postoverdose outreach programs aim to connect survivors with treatment and harm reduction services.

Purpose of the Study:

  • To assess the association between postoverdose outreach programs and opioid fatality rates in Massachusetts municipalities.
  • To compare opioid fatality rates in municipalities with and without these outreach programs.

Main Methods:

  • Retrospective interrupted time-series analysis of 93 Massachusetts municipalities from 2013 to 2019.
  • Examined quarterly opioid fatality rates and emergency medical services (EMS) response rates per 100,000 population.
  • Analyzed data based on the implementation of postoverdose outreach programs.

Main Results:

  • Implementation of postoverdose outreach programs was associated with a significant decrease in the opioid fatality rate over time.
  • A significant decrease was also observed in opioid-related EMS response rates.
  • No significant immediate change in opioid fatality rates was detected upon program implementation, but the trend decreased significantly over time.

Conclusions:

  • Postoverdose outreach programs are associated with reduced opioid fatality rates in municipalities with high EMS responses.
  • Further evaluation of program components like partnerships and law enforcement involvement is recommended.
  • These findings highlight the effectiveness of outreach programs in mitigating opioid-related mortality.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.3K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
313
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
363
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
933
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.3K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.6K